Treatment of Subclinical Hypothyroidism with TSH > 10 mIU/L or Elevated Thyroid Peroxidase Antibody
Not all patients with subclinical hypothyroidism require treatment. In nonpregnant patients, specific threshold findings determine when intervention is warranted and what the treatment goal should be.
Clinical Scenario
Subclinical hypothyroidism — elevated TSH with a normal free thyroxine level — in a nonpregnant patient where the TSH level exceeds 10 mIU per L, or the thyroid peroxidase (TPO) antibody is elevated. Most patients with subclinical hypothyroidism do not benefit from treatment unless one of these criteria is present.
Treatment Approach
When either threshold is met, a targeted thyroid hormone replacement therapy is indicated. The complete protocol — including initiation approach, monitoring parameters, and decision criteria — is available in the structured regimen below.
Treatment Goal
Normalisation of the TSH level to within the reference range of 0.4 to 4.5 mIU per L.
References
In nonpregnant patients with subclinical hypothyroidism, levothyroxine therapy should be considered when the TSH level is greater than 10 mIU per L or the TPO antibody level is elevated.
Most patients with subclinical hypothyroidism do not benefit from treatment unless the thyroid-stimulating hormone level is greater than 10 mIU per L or the thyroid peroxidase antibody is elevated.
Clinical hypothyroidism should be treated with levothyroxine to normalize the TSH level and relieve signs and symptoms (Figure 2).
View source ↗